Laurenz Schmitt1, Tamara Schumann, Christoph Löser, Edgar Dippel. Show Affiliations » 1. Department of Dermatology, Klinikum Ludwigshafen, Skin Cancer Center Rheinpfalz, Germany.
Abstract
Entities: Chemical Disease
Mesh： See more » Antineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useFemaleHumansIndoles/adverse effectsLung Injury/chemically inducedLung Injury/diagnosisLung Injury/prevention & controlMelanoma/complicationsMelanoma/drug therapyMelanoma/secondaryMiddle AgedSulfonamides/adverse effectsTreatment OutcomeVemurafenib
Substances： See more » Antineoplastic AgentsIndolesSulfonamidesVemurafenib
Year: 2013 PMID： 24192775 DOI： 10.1159/000355643
Source DB: PubMed Journal: Onkologie ISSN： 0378-584X